What Is The Current and Historic Market Size Analysis Of The Endovascular Stent Grafts Market?
The endovascular stent grafts market has seen considerable growth due to a variety of factors.
• The market size for endovascular stent grafts has seen significant expansion in recent times. The market is projected to escalate from $1.05 billion in 2024 to $1.45 billion in 2025, which corresponds to a compound annual growth rate (CAGR) of 37.8%.
The expansion witnessed during the historical phase can be associated with the increasing occurrence of aortic aneurysms, the aging population surge, elevated healthcare expenditure in developed zones, an upward trend in the count of ambulatory surgical centers, and a rise in the prevalence of chronic diseases.
What Is The Forecast For The Endovascular Stent Grafts Market Size?
The endovascular stent grafts market is expected to maintain its strong growth trajectory in upcoming years.
• The expansion of the endovascular stent grafts market is predicted to rise significantly in the forthcoming years, reaching a market value of $5.19 billion in 2029 with a compound annual growth rate of 37.6%.
The anticipated growth throughout the prognosticated period can be credited to a continued shift towards less invasive approaches, a rise in vascular conditions including atherosclerosis and pulmonary embolism, advantageous reimbursement plans, an expanding number of hospitals, and a surge in diabetes cases even among the younger population. Major trends during the prediction period encompass the integration of artificial intelligence, the innovation of leading-edge imaging technologies, the creation of patient-specific or adaptable stent grafts, the development of next-generation tissue-engineered vascular grafts, and advancements in technology.
What Are The Essential Drivers Behind The Growth Of The Endovascular Stent Grafts Market?
The upward trend in cardiovascular diseases is likely to drive the growth of the endovascular stent graft market. Cardiovascular disease (CVD) encompasses a range of conditions that affect the heart and blood vessels. The rise in these diseases is attributed to a mix of lifestyle habits, health conditions, genetic factors, and external factors. Endovascular stent grafts provide a vital solution for treating cardiovascular diseases, emphasising on lowering the level of invasiveness and enhancing patient results. These stent grafts strengthen the frail vessel wall, averting a rupture, and decreasing the chances of grave complications. For instance, data from December 2023, provided by the Australian Institute of Health and Welfare, a government agency in Australia, shows that doctor-verified deaths from coronary heart disease (CHD) escalated from 14,100 in 2021 to 14,900 in 2022. Consequently, the surge in cardiovascular diseases is propelling the endovascular stent grafts market.
How Is The Global Endovascular Stent Grafts Market Divided Into Key Segments?
The endovascular stent grafts market covered in this report is segmented –
1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts
2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts
3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease
Subsegments:
1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts
2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts
3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts
4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts
5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts
Pre-Book The Endovascular Stent Grafts Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Endovascular Stent Grafts Market?
Leading organizations in the endovascular stent grafts market are concentrating on the creation of groundbreaking products like thoracic aortic stent-grafts. These innovations aim to amplify the accuracy and effectiveness of handling thoracic aortic aneurysms and dissections, elevate patient health outcomes, and resolve intricate anatomical issues using enhanced technology and design upgrades. A thoracic aortic stent graft, which is a specific medical device used in endovascular surgery, is aimed at addressing diseases of the thoracic aorta, the part of the aorta found in the chest. This device offers a mix of safety, efficacy and convenience for treating thoracic aortic conditions. As an example, in February 2024, Endovastec - a medical device company originating from China, unveiled its Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and achieved its inaugural clinical application in Switzerland. The Hector system characterizes a considerable leap forward in the technology of endovascular stent grafts. The system's multi-branch design facilitates the treatment of intricate thoracic aortic issues by accommodating and preserving crucial branches of the aorta, including arteries that are vital for organ supply.
Who Are the Key Players In The Endovascular Stent Grafts Market?
Major companies operating in the endovascular stent grafts market are:
• Cardinal Health Inc.
• Abbott Laboratories
• Medtronic PLC
• Stryker Corporation
• Becton
• Dickinson and Company (BD)
• Boston Scientific Corporation
• Terumo Corporation
• Getinge AB
• Cook Group Incorporated
• Merit Medical Systems Inc.
• Biotronik SE & Co KG
• MicroPort Scientific Corporation
• Endologix LLC
• LeMaitre Vascular Inc.
• Lifetech Scientific Corporation
• W. L. Gore & Associates inc.
• Braile Biomedica
• BrosMed Medical BV
• Micro Interventional Devices Inc. (MID)
• Lombard Medical Inc.
What Are The Regional Insights Into The Endovascular Stent Grafts Market?
North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
